BAXTER INTERNATIONAL INC (BAX) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$26.24

From 52W high−4.74%

Volume2.55M

Market cap$13.97B

P/E (TTM)—

P/S (TTM)1.2x

Div yield0.15%

Key dataNov 4, 2026

Open

$26.24

From 52W high

−4.74%

Volume

2.55M

Market cap

$13.97B

ValuationView details →

P/E (Fwd)

13.2x

EV/EBITDA

25.9x

P/E (TTM)

—

RSI (14)

62.3

MomentumView details →

1D Return

+5.94%

YTD Return

+40.16%

SummaryUpdated Sep 1, 2026

Baxter International Inc. (NYSE:BAX) is a global healthcare company founded in 1931 and headquartered in Deerfield, Illinois. The company has evolved from its origins as a medical device manufacturer into a diversified healthcare products and services provider serving hospitals, dialysis centers, and other healthcare facilities worldwide. Baxter underwent a significant strategic transformation in recent years, completing the sale of its Kidney Care business (Vantive) to Carlyle Group in early 2025, allowing the company to focus on its core medical products, healthcare systems, and pharmaceutical businesses across approximately 100 countries.

Ask drillr about BAXTER INTERNATIONAL INC →

ValuationView details →

P/E (Fwd)

13.2x

P/E (TTM)

—

EV/EBITDA

25.9x

EV/Sales

1.8x

P/S (TTM)

1.2x

P/B (TTM)

2.1x

ProfitabilityView details →

Gross Margin

30.09%

Net Margin

−6.23%

EBITDA Margin

6.91%

ROE (TTM)

−11.12%

ROA (TTM)

−3.72%

Asset Turnover

0.59x

GrowthView details →

Revenue YoY

+5.33%

EPS YoY

—

FCF YoY

+334.78%

Revenue CAGR 3Y

+3.79%

EPS CAGR 3Y

−37.80%

EBITDA YoY

−22.66%

MomentumView details →

1D Return

+5.94%

YTD Return

+40.16%

1Y Return

+49.22%

RSI (14)

62.3

vs 50D SMA

+9.20%

vs 200D SMA

+25.04%

Capital & dividendView details →

Debt/Equity

1.35x

Current Ratio

1.79x

Quick Ratio

1.19x

Div Yield

0.15%

Div Rate

$0.04

Div Growth 1Y

−50.00%

EarningsView details →

EPS (Actual)

$0.58

EPS Surprise

11.75%

Beats (12Q)

10/12

Next Q EPS Est

$0.60

Avg Surprise (4Q)

15.92%

Rev Surprise

4.45%

Financials snapshotView financials →

Revenue (TTM)

11.61B

Net Income (TTM)

−723.00M

Op. CF (TTM)

1.64B

Next earningsFeb 11, 2027 →

Latest newsMore news →

Baxter International reported better-than-expected third-quarter financial results.6d ago

BAXTER INTERNATIONAL INC reported quarterly earnings of $0.58 per share, compared with $0.69 per share a year earlier.6d ago

Similar companies

Shandong Weigao Group Medical Polymer Company Limited01066.HK Angelalign Technology Inc.06699.HK 南微医学688029.SH The Cooper Companies, Inc.COO Shanghai Conant Optical Co., Ltd.02276.HK Hologic, Inc.HOLX Find similar companies →

Latest newsMore news →

Baxter International reported better-than-expected third-quarter financial results.6d ago BAXTER INTERNATIONAL INC reported quarterly earnings of $0.58 per share, compared with $0.69 per share a year earlier.6d ago Baxter International declared a quarterly cash dividend of $0.01 per share of common stock, payable January 4, 2027, to shareholders of record November 27, 2026.6d ago